Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?

L. G. Feun; N. Savaraj; P. Benedetto; S. Waldman; M. Collier; N. J. Clendennin

doi:10.1097/00000421-199410000-00019

Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?

L. G. Feun, N. Savaraj, P. Benedetto, S. Waldman, M. Collier, N. J. Clendennin

Medicine

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.

Original language	English (US)
Pages (from-to)	448-451
Number of pages	4
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	17
Issue number	5
DOIs	https://doi.org/10.1097/00000421-199410000-00019
State	Published - Jan 1 1994

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1097/00000421-199410000-00019

Fingerprint Dive into the research topics of 'Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?'. Together they form a unique fingerprint.

Cite this

@article{4880447bcf4544c5aefff66959bde778,

title = "Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?",

abstract = "Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.",

author = "Feun, {L. G.} and N. Savaraj and P. Benedetto and S. Waldman and M. Collier and Clendennin, {N. J.}",

year = "1994",

month = jan,

day = "1",

doi = "10.1097/00000421-199410000-00019",

language = "English (US)",

volume = "17",

pages = "448--451",

journal = "American Journal of Clinical Oncology",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Oral piritrexim in advanced bladder cancer

T2 - An effective drug after progression on MVAC chemotherapy?

AU - Feun, L. G.

AU - Savaraj, N.

AU - Benedetto, P.

AU - Waldman, S.

AU - Collier, M.

AU - Clendennin, N. J.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.

AB - Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0028041356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028041356&partnerID=8YFLogxK

U2 - 10.1097/00000421-199410000-00019

DO - 10.1097/00000421-199410000-00019

M3 - Article

C2 - 8092120

AN - SCOPUS:0028041356

VL - 17

SP - 448

EP - 451

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 5

ER -